Since NAFLD is a component of the metabolic syndrome and its consequences, it is not surprising that elevations in ALT activity are frequently present in persons with T2DM and cardiovascular disease and are associated with increased mortality [11]–[17]. This evidence concerns the gene GPT and type 2 diabetes mellitus.